AbCellera Biologics Inc. ABCL Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $102.06M-44.6% | $128.51M-17.8% | $108.16M-28.7% | $117.44M-32.2% | $184.27M+24.0% | ||
| $39.16M— | $39.41M— | $71.25M— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $664.6M-13.1% | $728.23M-3.1% | $695.14M-6.4% | $742.15M-3.8% | $764.98M-6.0% | ||
| $47.81M0.0% | $47.81M0.0% | $47.81M0.0% | $47.81M0.0% | $47.81M0.0% | ||
| $17.21M-7.6% | $38.38M-8.9% | $17.91M-16.6% | $18.26M-15.0% | $18.61M-13.4% | ||
| $642.52M+10.9% | $628.72M+3.2% | $660.85M+1.7% | $659.92M+3.0% | $579.23M-10.8% | ||
| $1.31B-2.8% | $1.36B-0.3% | $1.36B-2.6% | $1.4B-0.7% | $1.34B-8.1% | ||
| $20.81M-36.6% | $25.23M-26.6% | $31.77M-8.7% | $32.04M+20.5% | $32.8M+21.9% | ||
| $7.74M-58.8% | $13.53M0.0% | $15.69M+181% | $16.95M+165% | $18.79M+77.8% | ||
| $47.29M-37.3% | $64.31M-16.1% | $68.8M-13.5% | $67.02M-4.8% | $75.4M-28.1% | ||
| $321.74M+30.9% | $325.74M+43.0% | $323.15M+37.4% | $327.96M+41.9% | $245.83M+7.7% | ||
| $369.03M+14.9% | $390.05M+28.1% | $391.95M+24.5% | $394.99M+31.0% | $321.23M-3.6% | ||
| $816.53M+3.3% | $802.34M+3.2% | $794.47M+2.8% | $791.67M+2.8% | $790.07M+3.3% | ||
| -$72.65M-202% | -$29.48M-125% | -$20.54M-114% | $36.58M-81.9% | $71.31M-70.2% | ||
| $938.08M-8.3% | $966.9M-8.4% | $964.04M-10.6% | $1.01B-9.4% | $1.02B-9.5% | ||
| $1.31B-2.8% | $1.36B-0.3% | $1.36B-2.6% | $1.4B-0.7% | $1.34B-8.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Can AbCellera Biologics Inc. cover its short-term obligations?
- Its current ratio is 14.05 — current assets exceed current liabilities.
- Where does AbCellera Biologics Inc.'s balance sheet data come from?
- Every line is extracted from AbCellera Biologics Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.